India's health biotech sector at a crossroads

作者: Sarah E Frew , Rahim Rezaie , Stephen M Sammut , Monali Ray , Abdallah S Daar

DOI: 10.1038/NBT0407-403

关键词:

摘要: India's home-grown biotech companies must strike a balance between domestic and international markets.

参考文章(14)
Knowledge InFocus Programme on Skills, India Country Profile ,(2003)
Ernesto Zedillo, Making Business Work for the Poor ,(2004)
Olivier Nicolle, Times are changing... Pardès. pp. 43- 50 ,(2004)
S. Wild, G. Roglic, A. Green, R. Sicree, H. King, Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030 Diabetes Care. ,vol. 27, pp. 1047- 1053 ,(2004) , 10.2337/DIACARE.27.5.1047
Jyotsna Dhawan, Rajesh S. Gokhale, Inder M. Verma, Bioscience in India: times are changing. Cell. ,vol. 123, pp. 743- 745 ,(2005) , 10.1016/J.CELL.2005.11.018
Utkarsh Palnitkar, Growth of Indian biotech companies, in the context of the international biotechnology industry Journal of Commercial Biotechnology. ,vol. 11, pp. 146- 154 ,(2005) , 10.1057/PALGRAVE.JCB.3040112
Nandini K Kumar, Uyen Quach, Halla Thorsteinsdóttir, Hemlatha Somsekhar, Abdallah S Daar, Peter A Singer, Indian biotechnology-rapidly evolving and industry led Nature Biotechnology. ,vol. 22, ,(2004) , 10.1038/NBT1204SUPP-DC31
Dana Wilkie, India wants to be your biotech source The Scientist. ,vol. 18, pp. 51- 53 ,(2004)